Search - tctmd.com

Displaying 661 - 680 of 771

Sort: Relevancy | Date

News Daily News

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

L.A. McKeown

August 20, 2012

News Daily News

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

L.A. McKeown

August 20, 2012

Presentation

Initial and Chronic Response to Clopidogrel After Stenting for ACS and Influence on Clinical Outcomes

Presenter: Thomas Cuisset

August 17, 2012

News Daily News

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

L.A. McKeown

August 01, 2012

News Daily News

El Pantoprazol No es Necesariamente un PPI Seguro para Pacientes a Tratamiento con Terapia Antiplaquetaria Doble

L.A. McKeown

August 01, 2012

News Daily News

Stopping Clopidogrel 1 Year After MI Raises Risk in PCI Patients

Jason Kahn

July 20, 2012

News Daily News

Interrumpir el Clopidogrel 1 Año después de un IM Aumenta el Riesgo en Pacientes sometidos a PCI

Jason Kahn

July 20, 2012

News Daily News

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

July 12, 2012

News Daily News

Meta Análisis: Ajustar el Tratamiento según la Función Plaquetaria Mejora los Resultados

July 12, 2012

News Daily News

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

July 10, 2012

News Daily News

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

July 10, 2012

News Daily News

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

July 05, 2012

News Daily News

HORIZONS-AMI: Resultados Similares con Abciximab y Eptifibatide durante PCI Primaria

July 05, 2012

Presentation

Prolonged Clopidogrel Use After BMS and DES Placement: The VA Drug-Eluting Stent Study

Presenter: David P. Faxon

June 08, 2012

News Daily News

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Caitlin E. Cox

June 07, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

News Daily News

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

L.A. McKeown

June 01, 2012

News Daily News

Se Publica el GIFT: Confirmado el Papel del CYP2C19 en la Variabilidad de la Respuesta al Clopidogrel

L.A. McKeown

May 23, 2012

News Daily News

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

L.A. McKeown

May 23, 2012

News Conference News EuroPCR 2012

Statin Reloading Improves Clinical Outcomes in Stable PCI Patients

Jason Kahn

May 17, 2012

Advertisement

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

Initial and Chronic Response to Clopidogrel After Stenting for ACS and Influence on Clinical Outcomes

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

El Pantoprazol No es Necesariamente un PPI Seguro para Pacientes a Tratamiento con Terapia Antiplaquetaria Doble

Stopping Clopidogrel 1 Year After MI Raises Risk in PCI Patients

Interrumpir el Clopidogrel 1 Año después de un IM Aumenta el Riesgo en Pacientes sometidos a PCI

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

Meta Análisis: Ajustar el Tratamiento según la Función Plaquetaria Mejora los Resultados

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

HORIZONS-AMI: Similar Outcomes with Abciximab, Eptifibatide During Primary PCI

HORIZONS-AMI: Resultados Similares con Abciximab y Eptifibatide durante PCI Primaria

Prolonged Clopidogrel Use After BMS and DES Placement: The VA Drug-Eluting Stent Study

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

Se Publica el GIFT: Confirmado el Papel del CYP2C19 en la Variabilidad de la Respuesta al Clopidogrel

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

Statin Reloading Improves Clinical Outcomes in Stable PCI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content